首页> 美国卫生研究院文献>Non-coding RNA Research >Long non-coding RNAs in the failing heart and vasculature
【2h】

Long non-coding RNAs in the failing heart and vasculature

机译:衰竭的心脏和脉管系统中的长非编码RNA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following completion of the human genome, it became evident that the majority of our DNA is transcribed into non-coding RNAs (ncRNAs) instead of protein-coding messenger RNA. Deciphering the function of these ncRNAs, including both small- and long ncRNAs (lncRNAs), is an emerging field of research. LncRNAs have been associated with many disorders and a number have been identified as key regulators in the development and progression of disease, including cardiovascular disease (CVD). CVD causes millions of deaths worldwide, annually. Risk factors include coronary artery disease, high blood pressure and ageing. In this review, we will focus on the roles of lncRNAs in the cellular and molecular processes that underlie the development of CVD: cardiomyocyte hypertrophy, fibrosis, inflammation, vascular disease and ageing. Finally, we discuss the biomarker and therapeutic potential of lncRNAs.
机译:人类基因组完成后,很明显,我们的大多数DNA被转录为非编码RNA(ncRNA),而不是蛋白质编码的信使RNA。解密这些ncRNA的功能,包括小型和长型ncRNA(lncRNA),都是一个新兴的研究领域。 LncRNA已与许多疾病相关,并且已确定许多基因是疾病包括心血管疾病(CVD)发生和发展的关键调节因子。 CVD每年在全球造成数百万人死亡。危险因素包括冠状动脉疾病,高血压和衰老。在本文中,我们将重点关注lncRNA在CVD发展的细胞和分子过程中的作用:心肌细胞肥大,纤维化,炎症,血管疾病和衰老。最后,我们讨论了lncRNA的生物标志物和治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号